Therapeutic Area

Nephrology

Renal disease research excellence — CKD progression studies, dialysis efficacy trials, and biologic therapy monitoring, delivered with meticulous attention to patient safety and protocol compliance.

Initiate a Nephrology Trial

Overview

Renal Research, Managed with Precision.

Mayomi Research Solutions provides expert clinical trial management for nephrology studies, including chronic kidney disease (CKD) progression trials, acute kidney injury studies, dialysis efficacy research, and biologic therapies targeting glomerular and tubular disorders. Our team works closely with nephrologists, renal nurses, and dialysis unit staff to ensure protocol compliance and patient safety.

We have experience across IgA nephropathy, focal segmental glomerulosclerosis (FSGS), diabetic nephropathy, polycystic kidney disease, and renal transplant rejection prevention — managing complex inclusion criteria, frequent laboratory assessments, and renal endpoint adjudication.

CKD progression & eGFR decline studies
IgA nephropathy & glomerulonephritis trials
Dialysis (haemodialysis & peritoneal) efficacy studies
Renal transplant immunosuppression trials
Biologic therapies targeting podocyte disorders

At a Glance

Trial Phases Phase II, III, IV

Regulatory Bodies CDSCO, FDA, EMA

Key Endpoints eGFR, UPCR, serum creatinine, dialysis adequacy

Patient Population CKD Stages 2–5, transplant recipients

Study Types RCT, Open-label extension, Registry

Location Bengaluru, Renal units

Trial Capabilities

What We Deliver.

Specialized capabilities built for the unique demands of nephrology clinical research.

CKD Progression Studies

Management of long-term CKD progression trials including frequent eGFR monitoring, dietary compliance tracking, and protocol-defined renal endpoint adjudication.

Dialysis Efficacy Trials

Specialist coordination of haemodialysis and peritoneal dialysis efficacy studies — Kt/V measurement support, adequacy monitoring, and vascular access complication tracking.

Biologic Therapy Monitoring

Expert safety monitoring for biologic agents in nephrology including complement pathway inhibitors, anti-CD20 therapies, and novel podocyte-targeting treatments.